A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis.
Mouren A, Chansavang A, Hamzaoui N, Srikaran A, Laurent-Puig P, Marisa L, De Percin S, Lupo A, Larousserie F, Blons H, L'Haridon A, Burnichon N, Pasmant E, Tlemsani C.
Mouren A, et al.
Fam Cancer. 2024 Nov;23(4):627-634. doi: 10.1007/s10689-024-00393-0. Epub 2024 May 19.
Fam Cancer. 2024.
PMID: 38763984